Nicotinamide Riboside for Treating Elevated Systolic Blood Pressure and Arterial Stiffness in Middle-aged and Older Adults

A phase 2 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 118 participants.

Also called NCT03821623

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 118 participants (planned count) (from the registry)
Sponsor
Douglas Seals (from the registry)
Registry
  • NCT NCT03821623
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT03821623. Randomized; triple masking; primary purpose treatment. Start 2019-05-10 (actual); primary completion 2027-09-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Nicotinamide Riboside for Treating Elevated Systolic Blood Pressure and Arterial Stiffness in Middle-aged and Older Adults
Condition
Hypertension
Condition
Aging
Intervention (Drug)
Nicotinamide riboside
Intervention (Other)
Placebo
Lead sponsor
Douglas Seals (class: other)

Record details

Record id
cardio:ct-nct03821623
Content hash
b0fee8bdfd008d830eae5a094d1189de2d185baeebc5c682dfcf26d92ef6d627